Setting up econometric ARIMA methodology to elucidate European Union nosocomial antimicrobial resistance rate trend evolution based on largest EU database
14 September 2019
Econometric ARIMA model statistically proved slowdowns and reversions in increase trend of nosocomial E. coli and K. pneumoniae resistance to 3GC and FQ, as well as in resistance of P. aeruginosa resistance to 3GC. P. aeruginosa resistance to FQ shows a descending slope. These brakes and decreased trends proved constitute noteworthy milestones in tackling AMR in Europe.
Further reading: International Journal of Antimicrobial Agents
Author(s): Rafael Ortega-Huedo, Marina Cuesta, Andreas Hoefer, Bruno Gonzalez-Zorn
Effective Surveillance
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.